Dr. Christopher Brown, MD

NPI: 1194715813
Total Payments
$13,711
2024 Payments
$2,984
Companies
40
Transactions
809
Medicare Patients
2,804
Medicare Billing
$329,404

Payment Breakdown by Category

Food & Beverage$13,643 (99.5%)
Education$56.01 (0.4%)
Consulting$12.55 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,643 804 99.5%
Education $56.01 4 0.4%
Consulting Fee $12.55 1 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $3,271 193 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,975 151 $0 (2024)
Gilead Sciences, Inc. $1,291 60 $0 (2024)
Janssen Biotech, Inc. $868.90 55 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $810.06 43 $0 (2024)
Merck Sharp & Dohme LLC $647.61 38 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $628.01 38 $0 (2024)
GENZYME CORPORATION $429.12 14 $0 (2024)
Synergy Pharmaceuticals Inc $392.00 13 $0 (2018)
PFIZER INC. $388.93 25 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,984 151 ABBVIE INC. ($408.64)
2023 $1,993 106 AbbVie Inc. ($395.66)
2022 $2,045 117 ABBVIE INC. ($545.84)
2021 $1,557 110 AbbVie Inc. ($449.23)
2020 $1,064 79 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($369.09)
2019 $1,177 71 AbbVie, Inc. ($363.79)
2018 $1,609 93 AbbVie, Inc. ($441.61)
2017 $1,284 82 AbbVie, Inc. ($362.97)

All Payment Transactions

809 individual payment records from CMS Open Payments — Page 1 of 33

Date Company Product Nature Form Amount Type
12/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $23.43 General
Category: Gastroenterology
12/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $14.12 General
Category: Gastroenterology
12/20/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $7.28 General
Category: GASTROENTEROLOGY
12/18/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $24.10 General
Category: Rare Disease
12/18/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.05 General
Category: Immunology
12/16/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.08 General
Category: GASTROENTEROLOGY
12/12/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $17.75 General
Category: LIVER DISEASE
12/11/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $9.34 General
Category: GASTROENTEROLOGY
12/09/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.02 General
Category: Immunology
12/09/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $21.57 General
Category: Immunology
12/04/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $28.12 General
Category: THERAPY FOR CSID
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $11.93 General
Category: Gastroenterology
12/03/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $34.57 General
Category: ENDOCRINOLOGY
12/03/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $31.75 General
Category: Immunology
11/22/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $21.30 General
11/21/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.52 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/21/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $13.05 General
Category: IMMUNOLOGY
11/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $23.34 General
Category: Immunology
11/19/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $19.42 General
Category: Rare Disease
11/17/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $23.63 General
Category: LIVER DISEASE
11/15/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $9.57 General
Category: GASTROENTEROLOGY
11/14/2024 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $26.90 General
Category: HCV
11/14/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $25.26 General
11/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $23.03 General
Category: IMMUNOLOGY
11/11/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $16.42 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 590 627 $327,733 $68,586
2022 15 695 762 $384,997 $82,867
2021 13 786 858 $442,338 $97,910
2020 16 733 951 $357,843 $80,042
Total Patients
2,804
Total Services
3,198
Medicare Billing
$329,404
Procedure Codes
56

All Medicare Procedures & Services

56 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 79 79 $74,497 $16,524 22.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 130 146 $45,844 $12,005 26.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 77 77 $37,268 $8,803 23.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 86 87 $52,200 $7,222 13.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 55 56 $30,986 $5,730 18.5%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 29 29 $21,663 $5,143 23.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 41 60 $12,600 $3,731 29.6%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 19 19 $14,193 $3,422 24.1%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 24 24 $19,032 $2,250 11.8%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 12 12 $8,964 $1,513 16.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 23 23 $7,291 $1,245 17.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 15 15 $3,195 $996.52 31.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 127 127 $61,468 $15,944 25.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 68 69 $65,067 $14,053 21.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 102 118 $37,052 $11,321 30.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 103 106 $63,600 $8,525 13.4%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 41 41 $30,627 $7,605 24.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 63 104 $21,840 $5,909 27.1%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 32 32 $25,376 $4,538 17.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 43 43 $23,878 $4,421 18.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 19 19 $14,193 $3,508 24.7%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 17 17 $12,699 $2,504 19.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 21 21 $4,473 $1,383 30.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 18 18 $5,706 $1,177 20.6%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2022 11 17 $3,910 $927.44 23.7%

About Dr. Christopher Brown, MD

Dr. Christopher Brown, MD is a Gastroenterology healthcare provider based in Stockbridge, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194715813.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Brown, MD has received a total of $13,711 in payments from pharmaceutical and medical device companies, with $2,984 received in 2024. These payments were reported across 809 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($13,643).

As a Medicare-enrolled provider, Brown has provided services to 2,804 Medicare beneficiaries, totaling 3,198 services with total Medicare billing of $329,404. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Stockbridge, GA
  • Active Since 10/25/2005
  • Last Updated 09/05/2018
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1194715813

Products in Payments

  • XIFAXAN (Drug) $1,640
  • STELARA (Biological) $626.33
  • Humira (Biological) $598.66
  • DUPIXENT (Biological) $556.05
  • Linzess (Drug) $535.94
  • DIFICID (Drug) $516.10
  • RINVOQ (Biological) $399.19
  • Trulance (Drug) $392.00
  • ENTYVIO (Biological) $389.89
  • HUMIRA (Biological) $387.19
  • XELJANZ (Drug) $343.08
  • LINZESS (Drug) $340.35
  • MAVYRET (Drug) $331.63
  • Mavyret (Drug) $326.72
  • OCALIVA (Drug) $317.25
  • Entyvio (Biological) $315.70
  • CREON (Drug) $283.74
  • VIBERZI (Drug) $270.55
  • INJECTAFER (Drug) $265.59
  • ZENPEP (Drug) $245.93

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Stockbridge